These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35360801)
1. Changes in reverse transcription polymerase chain reaction cycle threshold values of SARS-CoV-2 with topical povidone iodine use: A single-arm open-label interventional study. Shankar S; Jamir L; Kakkar R; Babji K; Mangayarkarasi V; Tripathi M; Tak H J Family Med Prim Care; 2022 Feb; 11(2):480-486. PubMed ID: 35360801 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial. Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213 [TBL] [Abstract][Full Text] [Related]
3. Virucidal Effect of Povidone Iodine on SARS-CoV-2 in Nasopharynx: An Open-label Randomized Clinical Trial. Kamal Arefin M; Banu SS; Nasir Uddin AKM; Nurul Fattah Rumi SK; Khan M; Kaiser A; Arafat MS; Chowdhury JA; Khan MAS; Hasan MJ Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3283-3292. PubMed ID: 35572740 [TBL] [Abstract][Full Text] [Related]
4. Effect of 0.5% povidone-iodine on the nasopharyngeal and oropharyngeal viral loads in patients with COVID-19: A double-blind placebo-controlled randomized clinical trial. Sharma P; Singh A; Singh NP; Takhelchangbam N; Kumar R; Yadav R J Family Med Prim Care; 2022 Oct; 11(10):6320-6326. PubMed ID: 36618132 [TBL] [Abstract][Full Text] [Related]
5. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial. Arefin MK; Rumi SKNF; Uddin AKMN; Banu SS; Khan M; Kaiser A; Chowdhury JA; Khan MAS; Hasan MJ Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2963-2967. PubMed ID: 34026595 [TBL] [Abstract][Full Text] [Related]
6. The effects of mouth rinsing and gargling with mouthwash containing povidone-iodine and hydrogen peroxide on the cycle threshold value of Severe Acute Respiratory Syndrome Coronavirus 2: A randomized controlled trial of asymptomatic and mildly symptomatic patients. Sulistyani LD; Julia V; Soeprapto A; Swari RP; Rosmanato F; Haryanto B; Cahyarini C; Panjaitan R; Maharani DA F1000Res; 2022; 11():1238. PubMed ID: 38988895 [TBL] [Abstract][Full Text] [Related]
7. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial. Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769 [TBL] [Abstract][Full Text] [Related]
8. Effect of the povidone iodine, hypertonic alkaline solution and saline nasal lavage on nasopharyngeal viral load in COVID-19. Batioglu-Karaaltin A; Yigit O; Cakan D; Akgul O; Yigit E; Yilmaz YZ; Cakir KB; Ciftci G; Boyoğlu NS; Cagliyan A; Can E; Dikme O; Hacioglu Y; Balkan II; Enver O; Ozdogan HA Clin Otolaryngol; 2023 Jul; 48(4):623-629. PubMed ID: 36973223 [TBL] [Abstract][Full Text] [Related]
9. Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients. Buchan BW; Hoff JS; Gmehlin CG; Perez A; Faron ML; Munoz-Price LS; Ledeboer NA Am J Clin Pathol; 2020 Sep; 154(4):479-485. PubMed ID: 32687186 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management). Alsaleh S; Alhussien A; Alyamani A; Alhussain F; Alhijji A; Binkhamis K; Khan A; Javer A; Alshahrani FS BMC Infect Dis; 2024 Mar; 24(1):271. PubMed ID: 38429662 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of Real Time PCR Cycle Threshold Values in Symptomatic and Asymptomatic COVID-19 Patients]. Gülbudak H; Karvar Ş; Soydan G; Tezcan Ülger S; Kandemir Ö; Tamer L; Altunkan AA; Özdemir AA; Aslan G Mikrobiyol Bul; 2021 Jul; 55(3):435-444. PubMed ID: 34416808 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19. Arora R; Goel R; Kumar S; Chhabra M; Saxena S; Manchanda V; Pumma P Ophthalmology; 2021 Apr; 128(4):494-503. PubMed ID: 32882309 [TBL] [Abstract][Full Text] [Related]
13. Gargle lavage & saliva: Feasible & cheaper alternatives to nasal & throat swabs for diagnosis of COVID-19. Gupta A; Mittal A; Dhakad S; Brijwal M; Soneja M; Srigyan D; Xess A; Kumar A; Ray A; Meena VP; Garg RK; Singh K; Desai D; Chowdhury M; Chowdhury S; Sharma K; Narayan A; Krishnan GR; Naik S; Dar L; Pandey RM; Pandey S; Sinha S; Wig N Indian J Med Res; 2021 May; 153(5&6):665-670. PubMed ID: 34414924 [TBL] [Abstract][Full Text] [Related]
14. [Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers]. Ersoy L; Tezcan Ülger S; Gülbudak H; Yaşar N; Yapıcı G; Aslan G Mikrobiyol Bul; 2022 Jan; 56(1):114-123. PubMed ID: 35088965 [TBL] [Abstract][Full Text] [Related]
15. Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update. Chopra A; Sivaraman K; Radhakrishnan R; Balakrishnan D; Narayana A Jpn Dent Sci Rev; 2021 Nov; 57():39-45. PubMed ID: 33747261 [TBL] [Abstract][Full Text] [Related]
16. Effect of heat inactivation for the detection of severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) with reverse transcription real time polymerase chain reaction (rRT-PCR): evidence from Ethiopian study. Woldesemayat B; Gebremicael G; Zealiyas K; Yilma A; Adane S; Yimer M; Gutema G; Feleke A; Desta K BMC Infect Dis; 2022 Feb; 22(1):163. PubMed ID: 35189815 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of Real-Time Polymerase Chain Reaction in COVID-19 Patients. Lawrence Panchali MJ; Oh HJ; Lee YM; Kim CM; Tariq M; Seo JW; Kim DY; Yun NR; Kim DM Microbiol Spectr; 2022 Feb; 10(1):e0059121. PubMed ID: 35170995 [TBL] [Abstract][Full Text] [Related]
18. Infectivity assay for detection of SARS-CoV-2 in samples from patients with COVID-19. Hiroi S; Kubota-Koketsu R; Sasaki T; Morikawa S; Motomura K; Nakayama EE; Okuno Y; Shioda T J Med Virol; 2021 Oct; 93(10):5917-5923. PubMed ID: 34139026 [TBL] [Abstract][Full Text] [Related]